相关实验视频

Updated: May 7, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

双重功能纳米级协调聚合物纳米颗粒用于动脉样硬化向诊断和治疗

Yuanzhe Lin^1,2,3, Jingjing Liu^4,5, Suet Yen Chong^1,3,6

¹Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Rd, Singapore, 119228, Singapore.

Small (Weinheim an der Bergstrasse, Germany)

|August 26, 2024

概括

研究人员开发了用于动脉样硬化管理的新型纳米粒子. 这些纳米粒子通过释放抗炎药物并使MRI成像能够同时诊断和治疗动脉样硬化斑块,显示出对心血管疾病治疗的希望.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
心血管研究研究心血管研究

背景情况:

动脉样硬化导致心脏病发作和中风.
目前的治疗方法缺乏有效的非侵入性斑块成像和向性药物输送.
需要针对动脉样硬化进行先进的治疗系统.

研究的目的:

开发一种生物相容,可生物降解,pH响应的纳米级协调聚合物 (NCP) 系统,用于动脉样硬化管理.
创建能够同时诊断 (成像) 和治疗动脉样硬化斑块的纳米粒子.
在临床前模型中评估含有simvastatin的NCPs (ST/NCP-PEG) 的疗效和安全性.

主要方法:

合成的响应pH的NCPs使用化胺链接剂和Gd3+.
封装的simvastatin (ST) 在NCP上的脂质双层外内形成ST/NCP-PEG纳米粒子.
向动脉样硬化小鼠模型静脉注射纳米颗粒.
评估了斑块向,药物释放,抗炎作用,MRI成像和器官毒性.

主要成果:

ST/NCP-PEG纳米粒子成功准了动脉样硬化斑块.
药物释放是由斑块的温和酸性微环境触发的.
释放的simvastatin减少了炎症和氧化应激.
加多复合物能够有效地在体内进行斑块的MRI成像.
纳米粒子在减缓动脉样硬化进展方面表现出有效性,没有观察到毒性.

结论:

ST/NCP-PEG纳米颗粒代表了对动脉样硬化的一种有前途的治疗术策略.
该系统同时提供非侵入性诊断和针对心血管事件的向治疗.
响应pH的特性和双重功能解决了当前动脉样硬化管理中的局限性.

关键词:

动脉样硬化动脉样硬化磁共振成像技术的使用纳米级协调聚合物纳米级协调聚合物具有pH响应性的这是一个超神论者.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...